Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Ikena Oncology Inc (IKNA)

Ikena Oncology Inc (IKNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 69,009
  • Shares Outstanding, K 48,258
  • Annual Sales, $ 9,160 K
  • Annual Income, $ -68,170 K
  • 60-Month Beta 0.33
  • Price/Sales 7.38
  • Price/Cash Flow N/A
  • Price/Book 0.43
Trade IKNA with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.30
  • Number of Estimates 3
  • High Estimate -0.24
  • Low Estimate -0.41
  • Prior Year -0.44
  • Growth Rate Est. (year over year) +31.82%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.2200 +17.21%
on 04/18/24
1.4300 unch
on 05/17/24
+0.1900 (+15.32%)
since 04/17/24
3-Month
1.2200 +17.21%
on 04/18/24
1.6500 -13.33%
on 03/07/24
+0.0600 (+4.38%)
since 02/16/24
52-Week
1.0200 +40.20%
on 11/09/23
7.3800 -80.62%
on 06/16/23
-5.0500 (-77.93%)
since 05/17/23

Most Recent Stories

More News
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Ikena Oncology Inc. (NASDAQ: IKNA)

/PRNewswire/ -- Levi & Korsinsky announces that it has commenced an investigation of Ikena Oncology Inc. (NASDAQ: IKNA) concerning possible breaches of...

IKNA : 1.4300 (+2.14%)
Kronos Bio, Inc. (KRON) Reports Q1 Loss, Misses Revenue Estimates

Kronos Bio, Inc. (KRON) delivered earnings and revenue surprises of -6.98% and 89.15%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

KRON : 1.0200 (+3.89%)
IKNA : 1.4300 (+2.14%)
Why Ikena Oncology (IKNA) Might Surprise This Earnings Season

Ikena Oncology (IKNA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

IKNA : 1.4300 (+2.14%)
Exact Sciences (EXAS) Reports Q1 Loss, Tops Revenue Estimates

Exact Sciences (EXAS) delivered earnings and revenue surprises of 46.84% and 11.06%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

EXAS : 50.38 (-3.02%)
IKNA : 1.4300 (+2.14%)
Catalent (CTLT) to Report Q3 Earnings: What's in the Cards? (Revised)

Catalent's (CTLT) Q3 results are likely to have been driven by robust segmental performances.

CTLT : 55.37 (+0.22%)
NRIX : 16.59 (+7.73%)
IKNA : 1.4300 (+2.14%)
SRZN : 9.55 (-5.91%)
Harrow Health (HROW) to Report Q1 Earnings: What's in the Offing?

Harrow Health's (HROW) first-quarter top line is likely to have been driven by its recent product launches.

HROW : 16.76 (+3.71%)
IKNA : 1.4300 (+2.14%)
SRZN : 9.55 (-5.91%)
IVVD : 2.40 (-2.04%)
Catalent (CTLT) to Report Q3 Earnings: What's in the Cards?

Catalent's (CTLT) Q3 results are likely to have been driven by robust segmental performances.

CTLT : 55.37 (+0.22%)
IKNA : 1.4300 (+2.14%)
SRZN : 9.55 (-5.91%)
IVVD : 2.40 (-2.04%)
Revvity (PKI) to Report Q1 Earnings: Is a Beat in the Cards?

Revvity's (PKI) first-quarter results are likely to reflect weak performance at the Diagnostics segment, partially offset by strong demand for Life Sciences and Diagnostics franchise.

PKI : 115.24 (-0.91%)
IKNA : 1.4300 (+2.14%)
SRZN : 9.55 (-5.91%)
IVVD : 2.40 (-2.04%)
Ikena Oncology, Inc. (IKNA) Stock Jumps 7.9%: Will It Continue to Soar?

Ikena Oncology, Inc. (IKNA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength...

IKNA : 1.4300 (+2.14%)
RNA : 29.50 (+2.72%)
Here's Why Momentum in Ikena Oncology, Inc. (IKNA) Should Keep going

If you are looking for stocks that are well positioned to maintain their recent uptrend, Ikena Oncology, Inc. (IKNA) could be a great choice. It is one of the several stocks that passed through our "Recent...

IKNA : 1.4300 (+2.14%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Ikena Oncology Inc. is focused on developing cancer therapies targeting key signaling pathways which drive the formation and spread of cancer. The company's product candidates include IK-930, IK-175, IK-412 and IK-007, which are in clinical stage. Ikena Oncology Inc. is based in Boston, United States....

See More

Key Turning Points

3rd Resistance Point 1.5233
2nd Resistance Point 1.4767
1st Resistance Point 1.4533
Last Price 1.4300
1st Support Level 1.3833
2nd Support Level 1.3367
3rd Support Level 1.3133

See More

52-Week High 7.3800
Fibonacci 61.8% 4.9505
Fibonacci 50% 4.2000
Fibonacci 38.2% 3.4495
Last Price 1.4300
52-Week Low 1.0200

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar